The Latin America, Middle East and Africa Transcatheter Aortic Valve Replacement Market should witness market growth of 13.9% CAGR during the forecast period (2022-2028).
Manufacturers are concentrating on R&D cutting-edge and affordable valve replacement systems to enhance their market share. The need for AVR devices is driven by the increased prevalence of AS and valvular disorders, as these ailments can potentially cause fatal consequences such as heart failure and stroke. To stop the course of these illnesses and lower the risk of consequences, early diagnosis and treatment are essential.
As a result, the market share for aortic valve replacement devices is being driven by a rise in awareness regarding the significance of early identification and treatment of AS and valvular illnesses. According to numerous studies, TAVR devices are just as efficient as surgical aortic valve replacement devices, offering them a more appealing choice for patients and medical professionals. Moreover, favorable funding practices in several nations have aided in the uptake of TAVR devices and increased patient access to them.
The World Bank 2012 report estimates that 4.7% of the 336 million people in the Middle East and Northern Africa (MENA) are over 65. According to Statistics South Africa's most recent mid-year population forecasts, the estimated population of South Africa is 56.5 million people. In addition, the senior population in South Africa - defined as those who are 60 and older - grew to 8.1% in 2017. 4.6 million persons in South Africa are over the age of 60. 7.7% of the population is over 65; however, in Gauteng, they account for roughly 25% of the population. Less than 12% of the elderly reside in the Eastern Cape, where geriatrics comprise about 10% of the population.
The Brazil market dominated the LAMEA Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $171.1 million by 2028. The Argentina market is experiencing a CAGR of 14.5% during (2022-2028). Additionally, The UAE market would experience a CAGR of 13.6% during (2022-2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
Manufacturers are concentrating on R&D cutting-edge and affordable valve replacement systems to enhance their market share. The need for AVR devices is driven by the increased prevalence of AS and valvular disorders, as these ailments can potentially cause fatal consequences such as heart failure and stroke. To stop the course of these illnesses and lower the risk of consequences, early diagnosis and treatment are essential.
As a result, the market share for aortic valve replacement devices is being driven by a rise in awareness regarding the significance of early identification and treatment of AS and valvular illnesses. According to numerous studies, TAVR devices are just as efficient as surgical aortic valve replacement devices, offering them a more appealing choice for patients and medical professionals. Moreover, favorable funding practices in several nations have aided in the uptake of TAVR devices and increased patient access to them.
The World Bank 2012 report estimates that 4.7% of the 336 million people in the Middle East and Northern Africa (MENA) are over 65. According to Statistics South Africa's most recent mid-year population forecasts, the estimated population of South Africa is 56.5 million people. In addition, the senior population in South Africa - defined as those who are 60 and older - grew to 8.1% in 2017. 4.6 million persons in South Africa are over the age of 60. 7.7% of the population is over 65; however, in Gauteng, they account for roughly 25% of the population. Less than 12% of the elderly reside in the Eastern Cape, where geriatrics comprise about 10% of the population.
The Brazil market dominated the LAMEA Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $171.1 million by 2028. The Argentina market is experiencing a CAGR of 14.5% during (2022-2028). Additionally, The UAE market would experience a CAGR of 13.6% during (2022-2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
Scope of the Study
By Material
- Nitinol
- Stainless Steel
- Cobalt-Chromium
- Others
By Implantation Procedure
- Transfemoral
- Transapical
- Transaortic
By Mechanism
- Balloon-expanding Valve
- Self-expanding Valve
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- MicroPort Scientific Corporation
- LivaNova PLC
- TTK Healthcare Limited
- Meril Life Science Private Limited
- JenaValve Technology, Inc.
- Bracco S.p.A
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Transcatheter Aortic Valve Replacement Market, by Material
1.4.2 LAMEA Transcatheter Aortic Valve Replacement Market, by Implantation Procedure
1.4.3 LAMEA Transcatheter Aortic Valve Replacement Market, by Mechanism
1.4.4 LAMEA Transcatheter Aortic Valve Replacement Market, by End-use
1.4.5 LAMEA Transcatheter Aortic Valve Replacement Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Transcatheter Aortic Valve Replacement Market
Chapter 4. LAMEA Transcatheter Aortic Valve Replacement Market by Material
4.1 LAMEA Nitinol Market by Country
4.2 LAMEA Stainless Steel Market by Country
4.3 LAMEA Cobalt-Chromium Market by Country
4.4 LAMEA Others Market by Country
Chapter 5. LAMEA Transcatheter Aortic Valve Replacement Market by Implantation Procedure
5.1 LAMEA Transfemoral Market by Country
5.2 LAMEA Transapical Market by Country
5.3 LAMEA Transaortic Market by Country
Chapter 6. LAMEA Transcatheter Aortic Valve Replacement Market by Mechanism
6.1 LAMEA Balloon-expanding Valve Market by Country
6.2 LAMEA Self-expanding Valve Market by Country
Chapter 7. LAMEA Transcatheter Aortic Valve Replacement Market by End-use
7.1 LAMEA Hospitals Market by Country
7.2 LAMEA Ambulatory Surgical Centers Market by Country
7.3 LAMEA Others Market by Country
Chapter 8. LAMEA Transcatheter Aortic Valve Replacement Market by Country
8.1 Brazil Transcatheter Aortic Valve Replacement Market
8.1.1 Brazil Transcatheter Aortic Valve Replacement Market by Material
8.1.2 Brazil Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.1.3 Brazil Transcatheter Aortic Valve Replacement Market by Mechanism
8.1.4 Brazil Transcatheter Aortic Valve Replacement Market by End-use
8.2 Argentina Transcatheter Aortic Valve Replacement Market
8.2.1 Argentina Transcatheter Aortic Valve Replacement Market by Material
8.2.2 Argentina Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.2.3 Argentina Transcatheter Aortic Valve Replacement Market by Mechanism
8.2.4 Argentina Transcatheter Aortic Valve Replacement Market by End-use
8.3 UAE Transcatheter Aortic Valve Replacement Market
8.3.1 UAE Transcatheter Aortic Valve Replacement Market by Material
8.3.2 UAE Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.3.3 UAE Transcatheter Aortic Valve Replacement Market by Mechanism
8.3.4 UAE Transcatheter Aortic Valve Replacement Market by End-use
8.4 Saudi Arabia Transcatheter Aortic Valve Replacement Market
8.4.1 Saudi Arabia Transcatheter Aortic Valve Replacement Market by Material
8.4.2 Saudi Arabia Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.4.3 Saudi Arabia Transcatheter Aortic Valve Replacement Market by Mechanism
8.4.4 Saudi Arabia Transcatheter Aortic Valve Replacement Market by End-use
8.5 South Africa Transcatheter Aortic Valve Replacement Market
8.5.1 South Africa Transcatheter Aortic Valve Replacement Market by Material
8.5.2 South Africa Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.5.3 South Africa Transcatheter Aortic Valve Replacement Market by Mechanism
8.5.4 South Africa Transcatheter Aortic Valve Replacement Market by End-use
8.6 Nigeria Transcatheter Aortic Valve Replacement Market
8.6.1 Nigeria Transcatheter Aortic Valve Replacement Market by Material
8.6.2 Nigeria Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.6.3 Nigeria Transcatheter Aortic Valve Replacement Market by Mechanism
8.6.4 Nigeria Transcatheter Aortic Valve Replacement Market by End-use
8.7 Rest of LAMEA Transcatheter Aortic Valve Replacement Market
8.7.1 Rest of LAMEA Transcatheter Aortic Valve Replacement Market by Material
8.7.2 Rest of LAMEA Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.7.3 Rest of LAMEA Transcatheter Aortic Valve Replacement Market by Mechanism
8.7.4 Rest of LAMEA Transcatheter Aortic Valve Replacement Market by End-use
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Approvals and Trials:
9.1.6 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Approvals and Trials:
9.2.6 SWOT Analysis
9.3 Boston Scientific Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.3.5.2 Acquisition and Mergers:
9.3.5.3 Approvals and Trials:
9.4 Edwards Lifesciences Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 MicroPort Scientific Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 LivaNova PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 TTK Healthcare Limited
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Meril Life Sciences Private Limited
9.8.1 Company Overview
9.9 JenaValve Technology, Inc.
9.9.1 Company Overview
9.10. Bracco S.p.A.
9.10.1 Company Overview
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- MicroPort Scientific Corporation
- LivaNova PLC
- TTK Healthcare Limited
- Meril Life Science Private Limited
- JenaValve Technology, Inc.
- Bracco S.p.A
Methodology
LOADING...
